Ledger.Open graph →

SEC Form D · Amendment · filed September 25, 2013

TNI BIOTECH, INC

Offering

—

Sold

$2.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BETHESDA, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Noreen Griffin · BETHESDA, MDExec · Director Eugene Youkilis · BETHESDA, MDExec · Director Christopher Pearce · BETHESDA, MDExec · Director Peter Aronstam · BETHESDA, MDExec Noreen Griffin · Orlando, FLExec · Director Fengpin Shan · BETHESDA, MDExec · Director Gloria Herndon · BETHESDA, MDDirector Eugene Youkilis · Orlando, FLExec · Director Christopher Pearce · Orlando, FLExec · Director Peter Aronstam · Orlando, FLExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗